10914
R.H. Taaning et al. / Tetrahedron 65 (2009) 10908–10916
1.31 (s, 9H), 0.98 (t, J¼7.2 Hz, 3H). HRMS C14H22N2O3 [MþNaþ]
30.5, 29.0, 28.9, 26.9, 19.0, 13.6. HRMS C25H31NO5 [MþNaþ] calcu-
calculated: 289.1523, found: 289.1517.
lated: 448.2100, found: 448.2113.
4.3.3. (Z)-N-tert-Butyl-5-methyl-4-oxo-2-(5-oxopyrrolidin-2-ylide-
ne)hexanamide (9). The title compound was prepared according to
the general method above using N-iso-butyroyl succinimide
(73.8 mg, 0.436 mmol) and N-tert-butylacrylamide (63.8 mg,
0.502 mmol). Purification by column chromatography (increasing
polarity from 60% to 100% EtOAc in pentane) afforded the two pure
stereoisomers: 9 (Z-isomer) (93.2 mg, 0.332 mmol, 76%) as col-
ourless crystals and 9 (E-isomer) (16.4 mg, 0.058 mmol, 13%) as
a colourless solid. Compound 9 (Z-isomer): 1H NMR (400 MHz,
4.3.6. N,N-Di-n-butylacrylamide. Di-n-butylamine (1.00 g, 7.737
mmol) and triethylamine (1.95 mL, 14.00 mmol) were dissolved in
CH2Cl2 (20 mL) and then the mixture was cooled to 0 ꢁC. Acryloyl
chloride (0.63 mL, 700 mg, 7.737 mmol) was added dropwise, the
mixture was stirred at 0 ꢁC for 2 h and then at room temperature for
18 h. The mixture was poured into water (50 mL) and extracted with
CH2Cl2 (3ꢂ20 mL). The combined organic portions were dried
(MgSO4), filtered and evaporated in vacuo. The pure product was
obtained by column chromatography (increasing polarity from 5% to
35% EtOAc in pentane as eluant), which gave the title compound
(1.118 g, 6.10 mmol,79%)asacolourlessoil.1HNMR(400 MHz, CDCl3)
CD3CN)
2.72 (m, 3H), 2.42–2.36 (m, 2H), 1.31 (s, 9H), 1.07 (d, J¼6.8 Hz, 6H).
13C NMR (100 MHz, CD3CN)
(ppm) 214.2, 178.6, 169.5, 154.0, 98.6,
d (ppm) 10.88 (br s, 1H), 5.82 (br s, 1H), 3.33 (s, 2H), 2.83–
d
d
(ppm) 6.50 (dd, J¼16.4, 10.4 Hz, 1H), 6.47 (dd, J¼16.4, 2.0 Hz, 1H),
52.0, 40.6, 40.5, 29.0 (3C), 28.6, 26.5, 18.8. HRMS C15H24N2O3
5.60 (dd, J¼10.4, 2.0 Hz, 1H), 3.33 (t, J¼7.6 Hz, 2H), 3.25 (t, J¼7.6 Hz,
2H),1.56–1.45 (m, 4H),1.28 (app. hex, J¼7.2 Hz, 4H), 0.90 (t, J¼7.2 Hz,
[MþNaþ] calculated: 303.1679, found: 303.1686. Compound 9 (E-
isomer): 1H NMR (400 MHz, CD3CN)
d
(ppm) 8.06 (br s, 1H), 5.84 (br
3H), 0.88 (t, J¼7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3)
d (ppm) 165.8,
s, 1H), 3.33 (s, 2H), 3.05–2.99 (m, 2H), 2.72 (sept, J¼7.2 Hz, 1H),
2.43–2.37 (m, 2H), 1.30 (s, 9H), 1.06 (d, J¼7.2 Hz, 6H). HRMS
C15H24N2O3 [MþNaþ] calculated: 303.1679, found: 303.1683.
127.9 (2C),127.4 (2C), 47.9, 46.4, 31.8, 29.9, 20.3, 20.0,13.9,13.8. HRMS
C11H21NO [MþNaþ] calculated: 206.1521, found: 206.1518.
4.4. Experimental procedure for Scheme 6c
4.3.4. n-Butyl 2-(2-methyl-2-phenylpropionylamino)ethyl succinate
(18)14. N-Acyl oxazolidinone 16 (109 mg, 0.467 mmol) was dis-
N-Acyl oxazolidinone 17 (97 mg, 0.33 mmol) and N,N-di-n-
butylacrylamide (46 mg, 0.25 mmol) were dissolved in THF (5 mL)
and then water (36 mg, 2.00 mmol) was added. The mixture was
cooled to ꢀ78 ꢁC under a strict argon atmosphere before a solution
of SmI2 (10 mL, 1.00 mmol, 0.1 M in THF) was added dropwise over
5 min. The mixture was stirred at ꢀ78 ꢁC for 18 h, and then the flask
was flushed with oxygen to quench excess SmI2. It was poured into
satd aq Na2S2O3 (40 mL) and extracted with EtOAc (3ꢂ20 mL). The
combined organic portions were dried (MgSO4), filtered and
evaporated in vacuo. The pure products were obtained by column
chromatography (increasing polarity from 5% to 50% EtOAc in
pentane, and then 2% to 10% MeOH in DCM as eluant), which gave
the products 22 (21 mg, 0.053 mmol, 21%), 23 (18 mg, 0.037 mmol,
15%), 24 (69 mg, 0.144 mmol, 58%) and recovered N-acyl oxazoli-
dinone 17 (21 mg, 0.071 mmol, 23%).
solved in THF (7.5 mL), then water (54
mL, 3.00 mmol) and n-butyl
acrylate (216 L, 1.50 mmol) were added. The mixture was cooled
m
to ꢀ78 ꢁC and then SmI2 in THF (0.1 M, 15 mL, 1.50 mmol) was
added dropwise over 10 min. The mixture was stirred at ꢀ78 ꢁC
for 18 h and then the flask was flushed with O2. Satd aq NH4Cl
(5 mL) was added, and then the mixture poured into 0.5 M HCl
(40 mL) and extracted with EtOAc (3ꢂ15 mL). The combined or-
ganic portions were washed with satd aq Na2S2O5 (30 mL), dried
(MgSO4) filtered and evaporated in vacuo. The pure product was
obtained by column chromatography (increasing polarity from 5%
to 30% diethyl ether in 1:1 DCM/pentane as eluant), which gave
the title compound 18 (62 mg, 0.171 mmol, 36.5%) as a colourless
oil, and recovered 16 (15 mg, 0.063 mmol, 13.8%). 1H NMR
(400 MHz, CDCl3)
d
(ppm) 7.36–7.20 (m, 5H), 5.60 (br t, J¼5.2 Hz,
1H), 4.08 (t, J¼5.2 Hz, 2H), 4.03 (t, J¼6.8 Hz, 2H), 3.40 (q, J¼5.2 Hz,
2H), 2.49 (AA0BB0 system, 4H), 1.57 (pent, J¼7.2 Hz, 2H), 1.54 (s,
6H), 1.34 (hex, J¼7.6 Hz, 2H), 0.91 (t, J¼7.6 Hz, 3H). 13C NMR
4.4.1. N,N-Di-n-butyl-4-oxo-5,5-diphenylhexanamide (22). 1H NMR
(400 MHz, CDCl3)
d
(ppm) 7.34–7.17 (m, 10H), 3.27 (t, J¼7.6 Hz, 2H),
(100 MHz, CDCl3)
d
(ppm) 177.5, 172.3, 172.1, 145.0, 128.5 (2C),
3.21 (t, J¼7.6 Hz, 2H), 2.82 (t, J¼6.8 Hz, 2H), 2.47 (t, J¼6.8 Hz, 2H),
1.94 (s, 3H), 1.57–1.42 (m, 4H), 1.36–1.22 (m, 4H), 0.93 (t, J¼7.6 Hz,
126.3 (2C), 64.6, 63.1, 46.8, 38.6, 30.5, 29.0, 28.9, 26.8 (2C), 19.0,
13.6. HRMS C20H29NO5 [MþNaþ] calculated: 386.1944, found:
386.1943.
3H), 0.90 (t, J¼7.6 Hz, 3H). 13C NMR (100 MHz, CDCl3)
d (ppm) 221.2,
171.2, 144.1 (2C), 128.5 (4C), 128.4 (4C), 126.9 (2C), 61.9, 47.8, 46.1,
35.2, 31.2, 30.0, 27.6, 26.6, 20.4, 20.2, 14.0, 13.9. HRMS C26H35NO2
[MþNaþ] calculated: 416.2565, found: 416.2558.
4.3.5. n-Butyl 2-(2,2-diphenylpropanamido)ethyl succinate (19)14. N-
Acyl oxazolidinone 17 (138 mg, 0.467 mmol) was dissolved in THF
(7.5 mL), then water (54
m
L, 3.00 mmol) and n-butyl acrylate (216
m
L,
4.4.2. 2-(2,2-Diphenylpropanamido)ethyl 4-(di-n-butylamino)-4-oxo-
1.50 mmol) were added. The mixture was cooled to ꢀ78 ꢁC and then
SmI2 in THF (0.1 M, 15 mL, 1.50 mmol) was added dropwise over
10 min. The mixture was stirred at ꢀ78 ꢁC for 18 h and then the flask
was flushed with O2. Satd aq NH4Cl (5 mL) was added, and then the
mixture poured into 0.5 M HCl (40 mL) and extracted with EtOAc
(3ꢂ15 mL). The combined organic portions were washed with satd
aq Na2S2O5 (30 mL), dried (MgSO4), filtered and evaporated in vacuo.
The pure product was obtained by column chromatography (in-
creasing polarity from 5% to 20% diethyl ether in 1:1 pentane/DCM as
eluant), which gave the title compound 19 (115 mg, 0.270 mmol,
57.8%) as a colourless oil and recovered 17 (57 mg, 0.193 mmol,
butanoate (23). 1H NMR (400 MHz, CDCl3)
d (ppm) 7.34–7.20 (m,
10H), 6.00 (br t, J¼4.8 Hz, 1H), 4.15 (t, J¼4.8 Hz, 2H), 3.51 (q,
J¼4.8 Hz, 2H), 3.27–3.17 (m, 4H), 2.53 (AA0BB0 system, 4H), 1.99 (s,
3H), 1.58–1.49 (m, 2H), 1.49–1.40 (m, 2H), 1.37–1.20 (m, 4H), 0.95 (t,
J¼7.6 Hz, 3H), 0.89 (t, J¼7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3)
d
(ppm) 175.4, 173.3, 170.0, 145.1 (2C), 128.5 (4C), 128.3 (4C), 127.0
(2C), 63.1, 57.1, 47.7, 45.9, 39.0, 31.1, 30.0, 29.5, 28.2, 27.1, 20.4, 20.3,
14.0, 13.9. HRMS C29H40N2O4 [MþNaþ] calculated: 503.2886,
found: 503.2892.
4.4.3. N1,N1-Di-n-butyl-N3-(2-hydroxyethyl)-2-(2-oxo-3,3-diphe-
41.3%) as colourless solids. 1H NMR (400 MHz, CDCl3)
d
(ppm) 7.35–
nylbutyl)malonamide (24). 1H NMR (400 MHz, CDCl3)
d (ppm) 7.34–
7.20 (m, 10H), 5.82 (br t, J¼5.6 Hz, 1H), 4.14 (t, J¼5.6 Hz, 2H), 4.05 (t,
J¼6.8 Hz, 2H), 3.51 (q, J¼5.6 Hz, 2H), 2.51 (AA0BB0 system, 4H),1.99 (s,
3H), 1.59 (pent, J¼7.2 Hz, 2H), 1.35 (hex, J¼7.6 Hz, 2H), 0.93 (t,
7.20 (m, 6H), 7.17–7.09 (m, 4H), 7.00 (t, J¼6.0 Hz, 1H), 3.86 (dd,
J¼10.0, 3.2 Hz, 1H), 3.61 (ddd, J¼15.6, 10.0, 5.2 Hz, 1H), 3.55 (t,
J¼5.6 Hz, 2H), 3.46 (dt, J¼13.6, 7.2, 1H), 3.35 (dd, J¼18.4, 10.8 Hz,
1H), 3.33–3.15 (m, 4H), 2.89 (br s, 1H), 2.84 (dd, J¼18.4, 3.2 Hz, 1H)
1.89 (s, 3H), 1.70–1.45 (m, 4H), 1.37–1.23 (m, 4H), 0.93 (t, J¼7.2 Hz,
J¼7.6 Hz, 3H). 13C NMR (100 MHz, CDCl3)
d (ppm) 175.2, 172.1, 172.0,
144.8 (2C), 128.4 (4C), 128.0 (4C), 126.9 (2C), 64.6, 63.1, 56.9, 38.8,